Insilico Medicine's leadership to address key challenges in

Leadership from clinical stage artificial intelligence (AI)-powered drug discovery company Insilico Medicine ("Insilico") will attend the BIO International Convention in San Diego June 3-6 and present on key issues facing AI drug discovery.

Related Keywords

Montreal , Quebec , Canada , Boston , Massachusetts , United States , Hong Kong , Shanghai , China , San Diego , California , Suzhou , Jiangsu , Ashoka Madduri , Jue Wang , Michelle Chen , Abu Dhabi , Stacie Calad Thomson , Mathieu Blanchette , Christian Barrow , Petrina Kamya , Jimmy Yen Chu Lin , Alex Zhavoronkov , Martin Akerman , Andrew Giessel , Keith Mikule , Michael Bembem , Shell , Mcgill University , Business Development , Johnson , International Convention , Head Of Business Development , Astrazeneca , Insilico Medicine , Chief Business Officer Michelle Chen , Vice President , Insilico Medicine Taiwan , Insilico Vice President , Global Head , Experimental Validation , Drug Discovery , Vice Chairperson , Etai Jacob , Nature Biotechnology ,